home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Arysta LifeScience acquires South African biosolutions business
Arysta LifeScience adquire Verios, empresa de biossoluções da África do Sul


Cary, North Carolina, USA
June 5, 2017

Arysta LifeScience, a Platform Specialty Products company (NYSE: PAH), announced today it has acquired the business assets of Verios Agro Pty Ltd and Veriprod Pty Ltd (collectively, "Verios"). Founded in 2005, Verios is a South African biosolutions provider, specializing in the development and distribution of microbial and micronutrient-based biostimulants and innovative nutrition products for use in agriculture to support crop health and stimulate growth.

"We are very excited to combine Verios with our existing business," said Diego Lopez Casanello, President, Arysta LifeScience. "With this step, we add an innovative microbial technology platform to our biosolutions business that has growth potential both within South Africa as well as in other regions of the world."

"Arysta LifeScience is committed to strengthening its leadership in biosolutions around the world," Casanello added. "We will continue to evaluate opportunities in this exciting, high-growth market as a key pillar of our strategy."

"We are looking forward to joining Arysta LifeScience and continuing to execute our vision," said Daniel Marais, General Manager, Verios. "We believe our two businesses are highly complementary, and we are excited about the potential of our combined offering."


About Arysta LifeScience 

Arysta LifeScience is a global agricultural company specializing in the marketing and distribution of innovative crop protection and life science brands. With more than 200 active ingredients, Arysta LifeScience has a well-integrated biological and chemical portfolio to provide complete solutions to growers. The company's wide range of offerings includes biosolutions, fungicides, herbicides, insecticides and seed treatments. Arysta LifeScience, which has more than 3,000 employees working in over 60 countries to serve customers worldwide, had 2016 reventues of US$1.8 billion. Arysta LifeScience is owned by Platform Specialty Products Corporation (NYSE: PAH), a global innovator of technologically advanced specialty chemical products and provider of technical services (www.platformspecialtyproducts.com). For more information on Arysta LifeScience, visit www.arystalifescience.com

About Verios:

Verios was founded in 2005 in Pretoria, South Africa, in response to increasing demand for alternative, environmentally friendly crop solutions. The company focuses on the development, formulation, marketing, and distribution of microbial and micronutrient-based biosolutions. Its products are designed for agricultural use on a range of crops.


Arysta LifeScience adquire Verios, empresa de biossoluções da África do Sul

A Arysta LifeScience, empresa da Platform Specialty Products – fornecedor global de produtos químicos especializados em tecnologia avançada e serviços técnicos – adquiriu os ativos comerciais da Verios Agro Pty Ltd e da Veriprod Pty Ltd (conhecida como "Verios"), da África do Sul.

Fundada em 2005, a Verios é uma fornecedora sul-africana de biossoluções, especializada no desenvolvimento e distribuição de produtos biológicos, fisioativadores e nutrição inovadora para uso na agricultura, contribuindo para  a saúde das culturas e estimulando o desenvolvimento das plantas.

"Com este investimento, adicionamos uma inovadora plataforma de tecnologia para o nosso negócio de biossoluções, que tem potencial de crescimento tanto na África do Sul quanto em outras regiões do mundo", diz Diego Lopez Casanello, presidente da Arysta LifeScience. "Acreditamos que nossos dois negócios são altamente complementares e estamos entusiasmados com o potencial desse mercado”, ressalta Daniel Marais, Gerente Geral da Verios.

"A Arysta LifeScience está empenhada em fortalecer a liderança de biossoluções em todo o mundo", acrescenta Casanello. "Continuamos avaliando oportunidades nesse mercado de grande potencial de crescimento e pilar chave da nossa estratégia de atuação global".



More news from: Arysta LifeScience Corporation


Website: http://www.arystalifescience.com

Published: June 5, 2017

The news item on this page is copyright by the organization where it originated
Fair use notice


Copyright @ 1992-2025 SeedQuest - All rights reserved